1. Home
  2. CORT vs OLED Comparison

CORT vs OLED Comparison

Compare CORT & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • OLED
  • Stock Information
  • Founded
  • CORT 1998
  • OLED 1985
  • Country
  • CORT United States
  • OLED United States
  • Employees
  • CORT N/A
  • OLED N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • OLED Semiconductors
  • Sector
  • CORT Health Care
  • OLED Technology
  • Exchange
  • CORT Nasdaq
  • OLED Nasdaq
  • Market Cap
  • CORT 7.6B
  • OLED 7.4B
  • IPO Year
  • CORT N/A
  • OLED 1992
  • Fundamental
  • Price
  • CORT $72.87
  • OLED $136.51
  • Analyst Decision
  • CORT Strong Buy
  • OLED Strong Buy
  • Analyst Count
  • CORT 4
  • OLED 7
  • Target Price
  • CORT $139.00
  • OLED $190.43
  • AVG Volume (30 Days)
  • CORT 658.4K
  • OLED 555.8K
  • Earning Date
  • CORT 10-29-2025
  • OLED 10-29-2025
  • Dividend Yield
  • CORT N/A
  • OLED 1.32%
  • EPS Growth
  • CORT N/A
  • OLED 9.88
  • EPS
  • CORT 1.11
  • OLED 5.12
  • Revenue
  • CORT $716,080,000.00
  • OLED $661,991,000.00
  • Revenue This Year
  • CORT $30.62
  • OLED $6.28
  • Revenue Next Year
  • CORT $37.68
  • OLED $10.49
  • P/E Ratio
  • CORT $65.38
  • OLED $26.66
  • Revenue Growth
  • CORT 25.71
  • OLED 6.23
  • 52 Week Low
  • CORT $35.45
  • OLED $103.70
  • 52 Week High
  • CORT $117.33
  • OLED $215.90
  • Technical
  • Relative Strength Index (RSI)
  • CORT 56.90
  • OLED 39.20
  • Support Level
  • CORT $67.32
  • OLED $136.00
  • Resistance Level
  • CORT $72.52
  • OLED $147.51
  • Average True Range (ATR)
  • CORT 2.19
  • OLED 3.70
  • MACD
  • CORT 0.36
  • OLED -0.21
  • Stochastic Oscillator
  • CORT 74.30
  • OLED 10.79

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: